InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Karas Eric. Officer active across 1 company, notably ARS Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been published. Activity tracked since 19 August 2024. The latest transaction was disclosed on 20 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations